@article {Stradling181, author = {J R Stradling and S E Craig and M Kohler and D Nicoll and L Ayers and A J Nunn and D J Bratton}, title = {Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA}, volume = {70}, number = {2}, pages = {181--182}, year = {2015}, doi = {10.1136/thoraxjnl-2014-205958}, publisher = {BMJ Publishing Group Ltd}, abstract = {The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values \>0.13). Trial registration number: ISRCTN 34164388.}, issn = {0040-6376}, URL = {https://thorax.bmj.com/content/70/2/181}, eprint = {https://thorax.bmj.com/content/70/2/181.full.pdf}, journal = {Thorax} }